These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23227869)

  • 101. Topical antifungal-corticosteroid fixed-drug combinations: Need for urgent action.
    Rana P; Ghadlinge M; Roy V
    Indian J Pharmacol; 2021; 53(1):82-84. PubMed ID: 33976006
    [No Abstract]   [Full Text] [Related]  

  • 102. Drug-induced acne and rose pearl: similarities.
    Pontello R; Kondo RN
    An Bras Dermatol; 2013; 88(6):1039-40. PubMed ID: 24474128
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A cross-sectional survey of voriconazole prescribers: Assessing current practice and knowledge of cutaneous side effects.
    Chansky PB; Wanat K; Pappas-Taffer L; Rosenbach M; Micheletti RG
    J Am Acad Dermatol; 2017 Oct; 77(4):769-770. PubMed ID: 28917461
    [No Abstract]   [Full Text] [Related]  

  • 104. Bullous haemorrhagic eruption associated with frusemide.
    Ebringer A; Adam WR; Parkin JD
    Med J Aust; 1969 Apr; 1(15):768-71. PubMed ID: 4976857
    [No Abstract]   [Full Text] [Related]  

  • 105. Etisazole: an animal antifungal agent with skin sensitizing properties in man.
    Vanhee J; Ceuterick A; Dooms M; Dooms-Goossens A
    Contact Dermatitis; 1980 Oct; 6(6):443. PubMed ID: 7438745
    [No Abstract]   [Full Text] [Related]  

  • 106. Prescribing and cost analysis of treatments of cutaneous fungal infections.
    Peets EA
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):1013-5. PubMed ID: 10365939
    [No Abstract]   [Full Text] [Related]  

  • 107. [Clotrimazol in combination with other active ingredients].
    Reimann H
    Hautarzt; 2015 Oct; 66(10):795-6. PubMed ID: 26311033
    [No Abstract]   [Full Text] [Related]  

  • 108. Safety considerations in the treatment of dermatophytosis.
    Reed BR
    J Am Acad Dermatol; 2002 Sep; 47(3):455-6; author reply 456-7. PubMed ID: 12196764
    [No Abstract]   [Full Text] [Related]  

  • 109. Surrogate advertisement of a super-potent corticosteroid-containing cream: An alarming development and a cautionary tale of its consequences.
    Saraswat A; Damisetty R
    Indian J Dermatol Venereol Leprol; 2019; 85(1):104-106. PubMed ID: 30504534
    [No Abstract]   [Full Text] [Related]  

  • 110. Ketoconazole-induced fixed drug eruption.
    Bharija SC; Belhaj MS
    Int J Dermatol; 1988 May; 27(4):278-9. PubMed ID: 2968961
    [No Abstract]   [Full Text] [Related]  

  • 111. "Over the Internet" sale of prescription-level topical corticosteroids and dilemma of dermatologists.
    Bishnoi A; Handa S; Vinay K
    Int J Dermatol; 2018 Nov; 57(11):1403-1407. PubMed ID: 30191550
    [No Abstract]   [Full Text] [Related]  

  • 112. Time to reinvent the wheel for drug causality diagnostic approaches to severe cutaneous adverse reactions.
    Awad A; Trubiano JA
    Australas J Dermatol; 2023 Feb; 64(1):e79-e81. PubMed ID: 36652278
    [No Abstract]   [Full Text] [Related]  

  • 113. Caution in the use of camdogon.
    Schmeidler GA
    Vet Rec; 1968 Nov; 83(19):500. PubMed ID: 5748957
    [No Abstract]   [Full Text] [Related]  

  • 114. Facial telangiectasia and long-term corticosteroid use: a fallacy?
    Martin S
    J Am Acad Dermatol; 1990 Jul; 23(1):150. PubMed ID: 2365868
    [No Abstract]   [Full Text] [Related]  

  • 115. Severe cutaneous adverse reactions syndromes and prescribing autonomy.
    Walsh S; Creamer D
    Br J Dermatol; 2018 Aug; 179(2):242-243. PubMed ID: 30141544
    [No Abstract]   [Full Text] [Related]  

  • 116. Severe cutaneous adverse reactions: comparing outcomes in children with and without complex chronic conditions.
    Antoon JW; Goldman JL; Lee BR
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):790-792.e3. PubMed ID: 31421280
    [No Abstract]   [Full Text] [Related]  

  • 117. [Chromatographical aspects of hydrolysates of cutaneous inflammatory elements (erythema, bullae, papules and nodules)].
    CACCIALANZA P; GIANOTTI F
    G Ital Dermatol; 1954; 95(3):201-8. PubMed ID: 13200860
    [No Abstract]   [Full Text] [Related]  

  • 118. No excuse for prescribing combination antifungal/corticosteroid creams.
    Long SS
    J Pediatr; 2017 Jul; 186():2-3. PubMed ID: 28648273
    [No Abstract]   [Full Text] [Related]  

  • 119. Evaluation of Clotrimazole, a New Broad-spectrum Antifungal Agent For Dermatomycoses.
    Desai SC; Sheth R
    Indian J Dermatol Venereol Leprol; 1976; 42(1):13-21. PubMed ID: 28276418
    [No Abstract]   [Full Text] [Related]  

  • 120. Severe cutaneous allergic reactions following topical antifungal therapy.
    Tang MM; Corti MA; Stirnimann R; Pelivani N; Yawalkar N; Borradori L; Simon D
    Contact Dermatitis; 2013 Jan; 68(1):56-7. PubMed ID: 23227869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.